Sigyn Therapeutics, Inc. (SIGY) income statement
SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $48.16KP/E –Yield –
Sigyn Therapeutics, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2025
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2024
- 84.9%
Financial strength
- Current ratio
- 0.02
- Debt to equity
- -0.52
- Debt to assets
- 2278.2%
- Cash to current liabilities
- 2.1%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?